George Soros Astrazeneca PLC Transaction History

Soros Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$65.37 - $77.96 $27 Million - $32.2 Million	-413,303 Reduced 13.1%	2,742,498 $202 Million
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $31.8 Million - $40 Million	503,030 Added 18.96%	3,155,801 $207 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $15.4 Million - $17.6 Million	201,233 Added 8.21%	2,652,771 $207 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $137 Million - $166 Million	2,051,538 Added 512.88%	2,451,538 $191 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $24.4 Million - $27.8 Million	400,000 New	400,000 $27.1 Million

1,498

500M

5.59M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Soros Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Soros Fund Management LLC and George Soros with notifications on news.